The steady-state pharmacokinetics of oral ganciclovir in the fasting v
ersus fed state were studied in 20 patients infected with human immuno
deficiency virus and with a seropositive test result for cytomegalovir
us in a two-way crossover study. Patients received oral ganciclovir at
a dose of 1000 mg every 8 hours for 8 days. On days 4 and 8, subjects
were randomly assigned to receive the morning dose either after an ov
ernight fast or after a standardized 602-calorie, high-fat (46.5%) bre
akfast. Serial blood samples were obtained over the 8-hour morning dos
e interval. The mean time to maximum concentration (t(max)) was increa
sed from 1.8 hours in the fasting state to 3.0 hours in the fed state.
Mean maximum serum concentration (C-max) and area under the concentra
tion-time curve from time 0 to 8 hours (AUC(0-8)) of ganciclovir were
significantly higher in the fed state than after an overnight fast. Be
cause food could potentially increase the bioavailability of oral ganc
iclovir, patients should be instructed to take each dose of oral ganci
clovir with food.